GOLIMUMAB

Open Access
Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study
John D. Reveille, Atul Deodhar, Paul H. Caldron, Anna Dudek, Diane D. Harrison, Lilianne Kim, Kim Hung Lo, Jocelyn H. Leu and Elizabeth C. Hsia

The Journal of Rheumatology October 1 2019, 46 (10) 1277-1283; DOI: https://doi.org/10.3899/jrheum.180718
Open Access
Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study
Atul Deodhar, John D. Reveille, Diane D. Harrison, Lilianne Kim, Kim Hung Lo, Jocelyn H. Leu and Elizabeth C. Hsia

The Journal of Rheumatology March 1 2018, 45 (3) 341-348; DOI: https://doi.org/10.3899/jrheum.170487
You have access
Serum C-reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with Golimumab
Jürgen Braun, Xenofon Baraliakos, Kay-Geert A. Hermann, Stephen Xu and Benjamin Hsu

The Journal of Rheumatology September 1 2016, 43 (9) 1704-1712; DOI: https://doi.org/10.3899/jrheum.160003
You have access
Safety and Efficacy of Subcutaneous Golimumab in Patients with Active Rheumatoid Arthritis despite Methotrexate Therapy: Final 5-year Results of the GO-FORWARD Trial
Edward C. Keystone, Mark C. Genovese, Stephen Hall, Sang-Cheol Bae, Chenglong Han, Timothy A. Gathany, Stephen Xu, Yiying Zhou, Jocelyn H. Leu and Elizabeth C. Hsia

The Journal of Rheumatology February 1 2016, 43 (2) 298-306; DOI: https://doi.org/10.3899/jrheum.150712
You have access
The Effect of Golimumab Therapy on Disease Activity and Health-related Quality of Life in Patients with Ankylosing Spondylitis: 2-year Results of the GO-RAISE Trial
Désirée van der Heijde, Atul Deodhar, Jürgen Braun, Michael Mack, Benjamin Hsu, Timothy A. Gathany, Robert D. Inman, Chenglong Han and The GO-RAISE investigators

The Journal of Rheumatology June 1 2014, 41 (6) 1095-1103; DOI: https://doi.org/10.3899/jrheum.131003
You have access
Tuberculosis Risk in Patients Treated with Non-Anti-Tumor Necrosis Factor-α (TNF-α) Targeted Biologics and Recently Licensed TNF-α Inhibitors: Data from Clinical Trials and National Registries
Fabrizio Cantini, Laura Niccoli and Delia Goletti

The Journal of Rheumatology Supplement May 1 2014, 91 56-64; DOI: https://doi.org/10.3899/jrheum.140103
You have access
Evaluation of Serum Biomarkers Associated with Radiographic Progression in Methotrexate-naive Rheumatoid Arthritis Patients Treated with Methotrexate or Golimumab
Carrie Wagner, Dion Chen, Hongtao Fan, Elizabeth C. Hsia, Michael Mack, Paul Emery and Roy M. Fleischmann

The Journal of Rheumatology May 1 2013, 40 (5) 590-598; DOI: https://doi.org/10.3899/jrheum.120889

Main menu

User menu

Search

GOLIMUMAB

Content

Resources

Subscribers

More